FDA Appeals Against Morning-After Pill For All Ages

By Admin
Written by Robert Spence On Wednesday the Food and Drug Administration appealed a court order addressing the agency to make the “morning-after&r...

Written by Robert Spence

 

On Wednesday the Food and Drug Administration appealed a court order addressing the agency to make the “morning-after” pill available over-the-counter to women of all ages. According to court documents, lawyers with the Justice department filed the appeal with the 2nd U.S. Circuit Court of Appeals in New York.

READ THE APRIL EDITION OF HEALTHCARE GLOBAL HERE

Known as “Plan B”, the appeal is the latest incursion in the years-long legal battle over the drug, which has sparked outcry from both political and religious sects. The government is seeking to overturn U.S. District Judge Edward Korman’s ruling from April 5th that requires the FDA to make the emergency contraception available within 30 days to all girls of reproductive age. 

According to FDA spokeswoman Erica Jefferson, the Justice Department has asked the district court to temporarily stop its order from taking effect while the appeal is pending.

The ruling comes in response to a lawsuit filed originally in 2005 by the Center for Reproductive Rights and other groups against age and access limits to the emergency contraception. The groups argue that there is no scientific proof that girls of reproductive age could not safely use the drug without supervision.

Read Related Articles On Healthcare Global

The FDA has originally approved over-the-counter sales with no age limits but the order was reversed in a surprise December 2011 decision by U.S. Health and Human Services Secretary Kathleen Sebelius. President Barack Obama supported that restriction, barring girls from under 17 from buying the pills without a prescription.

In his ruling, Korman calls Sebelius’ decision “arbitrary, capricious and unreasonable.”

“The motivation for the secretary’s action was obviously political,” he wrote.

The agency confirms its decision to lower the age limit for Plan B One-Step was based on scientific data submitted by Teva that showed girls as young as 15 could safely use the drug without the intervention of a healthcare provider. In addition, cashiers will still have to  verify the customer’s age before selling it, the FDA said.

Share
Share

Featured Articles

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Costco move to partner with online healthcare provider Sesame to provide members with weight-loss drugs including Wegovy signals US anti-obesity boom

AstraZeneca Company Profile, as CEO Soriot Lands pay Deal

As it's announced AstraZeneca's CEO Pascal Soriot's package could rise by as much as US$24mn we explore the history of the UK's most valuable business

US Academic Medical Centres 'Struggling' says McKinsey

McKinsey report reveals cost inflation is forcing AMCs to find operational efficiencies, or face cutting back on crucial training & education programmes

J&J Community Initiatives Tackle US Healthcare Chasm

Medical Devices & Pharma

PitchBook: Healthcare Private Equity Deals see Decline

Health Insurance & Finance

McKinsey: ‘Women’s Healthcare Neglected for Decades'

Digital Healthcare